Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Hikaru NAGAHARA"'
Autor:
Tomomi Kogiso, Hikaru Nagahara, Etsuko Hashimoto, Shunichi Ariizumi, Masakazu Yamamoto, Keiko Shiratori
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e100495 (2014)
Transforming growth factor-β1 (TGF-β1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-β1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation
Externí odkaz:
https://doaj.org/article/81f425db2dea4e47a89f791943d67c29
Autor:
Tomoko Nakagami, Moritoshi Kurita, Junko Oya, Junichi Ishigami, Yoshihiko Naito, Hikaru Nagahara, Tetsuya Babazono
Publikováno v:
Asia Pacific Journal of Public Health. 35:224-226
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc357b32b601ca1b1432b28e73d21975
https://doi.org/10.1177/10105395231151285
https://doi.org/10.1177/10105395231151285
Autor:
Tomohito Nagai, Sayaka Ono, Kazuyuki Nishimura, Kazuki Sato, Masaru Komino, Kazuhiro Abe, Hikaru Nagahara
Publikováno v:
JMA Journal
A 30 year-old man with a high fever (37.5°C-40°C), vomiting, slurred speech, and mild cognitive impairment was admitted to our Emergency Department. He had traveled from Spain to the UK on business at the end of February 2020. A nasopharyngeal swab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5c8de11e3844bcadbb1004e687135e
https://doi.org/10.31662/jmaj.2021-0023
https://doi.org/10.31662/jmaj.2021-0023
Publikováno v:
Hepatology International. 7:937-944
Liver transplantation is currently the only curative therapeutic option for end-stage liver cirrhosis. However, due to the limitations of donor liver availability and occasional rejection, it cannot always be successfully applied. In this study, we d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27198c32fdf07637e4f6d70410c709a
https://doi.org/10.1007/s12072-013-9432-5
https://doi.org/10.1007/s12072-013-9432-5
Autor:
Meiko Shouzushima, Hikaru Nagahara, Mikiko Fujita, Saeko Kasajima, Naho Nagatani, Akiko Niimi, Yuri Nakamura, Maiko Furukawa, Ayumi Taguchi, Akira Takinishi, Ryoichi Misaka
Publikováno v:
Internal Medicine. 49:1537-1540
Herbal preparations are widely available and often regarded by the public as harmless remedies for a variety of medical ailments. However, some of these products or their metabolites can cause adverse effects such as liver damage. In this case report
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f623440449924779e77ffddb36d4a8
https://doi.org/10.2169/internalmedicine.49.3509
https://doi.org/10.2169/internalmedicine.49.3509
Publikováno v:
Internal Medicine. 47:1-6
Objective The aim of this study is to identify risk factors for asymptomatic cerebral infarction (ACI) in the general Japanese population. Materials and Methods A total of 634 subjects (272 men aged 55.4±8.8 years and 362 women aged 55.2±8.5 years)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8a31072a7db24ed611f51ba389b51a
https://doi.org/10.2169/internalmedicine.47.0341
https://doi.org/10.2169/internalmedicine.47.0341
Publikováno v:
Biomaterials. 28:1093-1104
The suppression of the detachment-induced cell death (anoikis) by the interaction between the cells and extracellular matrix (ECM) is necessary for the application of liver tissue engineering because the disruption of interaction with ECM leads hepat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2492115aa9b196290b137445931e315
https://doi.org/10.1016/j.biomaterials.2006.10.008
https://doi.org/10.1016/j.biomaterials.2006.10.008
Autor:
Etsuko Hashimoto, Takaji Furukawa, Kohji Ishida, Kazuko Takatsu, Keiko Shiratori, Katsutoshi Tokushige, Katsumi Yamauchi, Tatsuji Komatsu, Toshimi Nakanishi, Hikaru Nagahara, Naoko Yamaguchi
Publikováno v:
Hepatology. 42:149-155
We have previously reported an immunoglobulin (Ig) M autoantibody to hepatocyte-related 190-kd molecules in patients with type 1 autoimmune hepatitis (AIH). This molecule was first isolated by hepatocyte-specific human monoclonal antibody (MoAb). To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e1fa31cedcb68a8adc83b02e5e8ff1
https://doi.org/10.1002/hep.20726
https://doi.org/10.1002/hep.20726
Autor:
Tomoko SHIGA, Akiko SAITO, Katsutoshi TOKUSHIGE, Junko TAHARA, Koichi HARUYAMA, Takuma NARITOMI, Hikaru NAGAHARA, Naoaki HAYASHI, Ikuo IKEDA
Publikováno v:
Kanzo. 44:407-414
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f538242d50d6f70e886d5d6df7dca071
https://doi.org/10.2957/kanzo.44.407
https://doi.org/10.2957/kanzo.44.407
Autor:
Shunichi Ariizumi, Etsuko Hashimoto, Tomomi Kogiso, Keiko Shiratori, Hikaru Nagahara, Masakazu Yamamoto
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 6, p e100495 (2014)
PLoS ONE, Vol 9, Iss 6, p e100495 (2014)
Transforming growth factor-β1 (TGF-β1) potently inhibits human hepatocellular carcinoma (HCC) cell growth. Here we demonstrated that TGF-β1-induced apoptosis is mediated by decreased phosphorylation of cdc2 at Tyr15 accompanied by down-regulation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea8d1153ff90b27563d7e0bdca66b583
http://europepmc.org/articles/PMC4069002
http://europepmc.org/articles/PMC4069002